Open access
Oct 2026
Multi-Omics Prioritization and Clinical Evaluation of CYP4V2 as a Candidate Biomarker in Venous Thromboembolism
Background Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, has a substantial genetic component, but the effector genes and clinically relevant biomarkers remain incompletely defined. Methods We analyzed FinnGen R12 genome-wide association study (GWAS) summary statistics for VTE and...
Chen Zhang, Jie Xu, Ming Zhang et al.
· International Journal of Gen... · 0 citations